Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,7.157223521504924e-30,134.68930041152262,9038.922266662119,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.082752044757933e-27,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.9585833424351318e-17,inf,inf,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",2.8497387632431167e-15,0,0,37
3,Nonalcoholic fatty liver disease WP4396,3.7655474075176576e-10,10.28076923076923,223.09225728202367,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.9330816540203965e-08,0,0,33
4,Oxidative phosphorylation WP623,4.031727359478208e-10,inf,inf,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF']",2.9330816540203965e-08,0,0,21
5,Mitochondrial complex I assembly model OXPHOS system WP4324,7.293978834550964e-08,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",4.245095681708661e-06,0,0,16
6,Mitochondrial CIV Assembly WP4922,5.784841264148273e-07,inf,inf,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",2.805648013111912e-05,0,0,14
7,Mitochondrial complex III assembly WP4921,0.0007827935823079733,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1']",0.0325418474930886,0,0,7
8,Amino Acid metabolism WP3925,0.002182391158398234,inf,inf,"['LDHA', 'PKM', 'GOT1', 'GSS', 'ODC1', 'SRM']",0.07056398078820957,0,0,6
9,Glycolysis and Gluconeogenesis WP534,0.002182391158398234,inf,inf,"['LDHA', 'PKM', 'GOT1', 'PGAM1', 'ALDOC', 'PFKM']",0.07056398078820957,0,0,6
10,Pathways in clear cell renal cell carcinoma WP4018,0.0060772758626536855,inf,inf,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.17684872760322226,0,0,5
11,7q11.23 copy number variation syndrome WP4932,0.025551760538611988,8.914233576642335,32.68893184969452,"['ATP5MC2', 'EIF4H', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.6759602106123717,0,0,5
12,Ferroptosis WP4313,0.029422394703718154,5.3528336380255945,18.874086964752422,"['MAP1LC3A', 'GPX4', 'GSS', 'VDAC3', 'SAT2', 'FTL']",0.686786485217957,0,0,6
13,mRNA Processing WP411,0.030681183188431074,4.166666666666667,14.517107240678563,"['SF3B5', 'LSM7', 'SF3A1', 'SNRPD1', 'SNRPE', 'SNU13', 'SRSF9']",0.686786485217957,0,0,7
14,Cellular Proteostasis WP4918,0.04696126249658134,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.8541079616565732,0,0,3
15,Computational Model of Aerobic Glycolysis WP4629,0.04696126249658134,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.8541079616565732,0,0,3
16,Glycolysis in senescence WP5049,0.04696126249658134,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.8541079616565732,0,0,3
17,DNA Repair Pathways Full Network WP4946,0.058499728609506044,3.121794871794872,8.861942633484617,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'CENPX', 'POLE2', 'APEX1']",0.8868029888187015,0,0,7
18,Base Excision Repair WP4752,0.060208655617887824,7.118397085610201,20.00226269863319,"['POLE4', 'NEIL2', 'APEX1', 'POLE2']",0.8868029888187015,0,0,4
19,Corticotropin-releasing hormone signaling pathway WP2355,0.060208655617887824,7.118397085610201,20.00226269863319,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.8868029888187015,0,0,4
20,Proteasome Degradation WP183,0.06162234478401687,3.5648994515539307,9.934414866037374,"['PSMD8', 'PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.8868029888187015,0,0,6
21,Proximal tubule transport WP4917,0.11891250762477876,2.9653284671532845,6.31427343117527,"['ATP6V1G1', 'ATP1A1', 'ATP6V0C', 'ATP6V1D', 'ATP6V1F']",0.8868029888187015,0,0,5
22,Acute viral myocarditis WP4298,0.12952248783401926,3.5555555555555554,7.267202708231913,"['ENDOG', 'TGFB1', 'CYCS', 'BAX']",0.8868029888187015,0,0,4
23,Aryl Hydrocarbon Receptor Pathway WP2873,0.12952248783401926,3.5555555555555554,7.267202708231913,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.8868029888187015,0,0,4
24,Translation Factors WP107,0.12952248783401926,3.5555555555555554,7.267202708231913,"['EEF1B2', 'EIF3I', 'EIF4H', 'EIF3D']",0.8868029888187015,0,0,4
25,GABA receptor Signaling WP4159,0.12952248783401926,3.5555555555555554,7.267202708231913,"['GABBR1', 'SLC32A1', 'SLC6A1', 'GABRD']",0.8868029888187015,0,0,4
26,Amyotrophic lateral sclerosis (ALS) WP2447,0.13031569589924463,inf,inf,"['TOMM40', 'BAX']",0.8868029888187015,0,0,2
27,CAMKK2  Pathway WP4874,0.13031569589924463,inf,inf,"['FIS1', 'MAP1LC3A']",0.8868029888187015,0,0,2
28,Type II diabetes mellitus WP1584,0.13031569589924463,inf,inf,"['SURF1', 'PRKCD']",0.8868029888187015,0,0,2
29,Urea cycle and metabolism of amino groups WP497,0.13031569589924463,inf,inf,"['ODC1', 'SRM']",0.8868029888187015,0,0,2
30,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.13031569589924463,inf,inf,"['TGFB1', 'VIP']",0.8868029888187015,0,0,2
31,Cori Cycle WP1946,0.13031569589924463,inf,inf,"['LDHA', 'PGAM1']",0.8868029888187015,0,0,2
32,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.13031569589924463,inf,inf,"['H3F3B', 'H2AFZ']",0.8868029888187015,0,0,2
33,Gastric acid production WP2596,0.13031569589924463,inf,inf,"['CCK', 'VIP']",0.8868029888187015,0,0,2
34,Glutathione metabolism WP100,0.13031569589924463,inf,inf,"['GPX4', 'GSS']",0.8868029888187015,0,0,2
35,Histone Modifications WP2369,0.13031569589924463,inf,inf,"['SET', 'H3F3B']",0.8868029888187015,0,0,2
36,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.13031569589924463,inf,inf,"['SFRP1', 'TGFB1']",0.8868029888187015,0,0,2
37,NO/cGMP/PKG mediated Neuroprotection WP4008,0.13031569589924463,inf,inf,"['PDE3A', 'CYCS']",0.8868029888187015,0,0,2
38,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.13031569589924463,inf,inf,"['EIF3I', 'EIF3D']",0.8868029888187015,0,0,2
39,Osteoclast Signaling WP12,0.13031569589924463,inf,inf,"['AIMP2', 'ATP6V1G1']",0.8868029888187015,0,0,2
40,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.13031569589924463,inf,inf,"['TGFB1', 'BAX']",0.8868029888187015,0,0,2
41,SARS-CoV-2 mitochondrial interactions WP5038,0.13031569589924463,inf,inf,"['NDUFB9', 'PHB']",0.8868029888187015,0,0,2
42,Differentiation Pathway WP2848,0.13713448280701568,5.329090909090909,10.587801624624356,"['TGFB1', 'KIT', 'FGF1']",0.8868029888187015,0,0,3
43,Metabolic reprogramming in colon cancer WP4290,0.13713448280701568,5.329090909090909,10.587801624624356,"['LDHA', 'PKM', 'PGAM1']",0.8868029888187015,0,0,3
44,Nucleotide metabolism WP404,0.13713448280701568,5.329090909090909,10.587801624624356,"['NME2', 'OAZ1', 'SRM']",0.8868029888187015,0,0,3
45,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.13713448280701568,5.329090909090909,10.587801624624356,"['NDUFA13', 'HSP90AA1', 'AAMP']",0.8868029888187015,0,0,3
46,Synaptic Vesicle Pathway WP2267,0.21824424905706288,2.3679417122040074,3.604339827545882,"['RAB3A', 'SLC32A1', 'PARK7', 'CPLX3']",0.9922811513964994,0,0,4
47,Pancreatic adenocarcinoma pathway WP4263,0.21824424905706288,2.3679417122040074,3.604339827545882,"['TGFB1', 'PRKCD', 'BAX', 'GADD45G']",0.9922811513964994,0,0,4
48,Selenium Micronutrient Network WP15,0.23723420458911476,1.776965265082267,2.556533113347103,"['SELENOM', 'GPX4', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9922811513964994,0,0,6
49,Pyrimidine metabolism WP4022,0.23723420458911476,1.776965265082267,2.556533113347103,"['POLE4', 'POLE2', 'NME2', 'POLR2I', 'POLR2K', 'POLR2L']",0.9922811513964994,0,0,6
50,DNA IR-double strand breaks and cellular response via ATM WP3959,0.2525232154877785,2.6618181818181816,3.663332841163926,"['DCLRE1C', 'KAT5', 'BAX']",0.9922811513964994,0,0,3
51,Nanomaterial induced apoptosis WP2507,0.2525232154877785,2.6618181818181816,3.663332841163926,"['ENDOG', 'BAX', 'CYCS']",0.9922811513964994,0,0,3
52,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.2525232154877785,2.6618181818181816,3.663332841163926,"['LDHA', 'PKM', 'BAX']",0.9922811513964994,0,0,3
53,Rett syndrome causing genes WP4312,0.2525232154877785,2.6618181818181816,3.663332841163926,"['IMPDH2', 'HAP1', 'GABRD']",0.9922811513964994,0,0,3
54,Hepatitis B infection WP4666,0.27301632881143667,1.7755474452554745,2.3050577261247165,"['TGFB1', 'ATP6AP1', 'VDAC3', 'CYCS', 'BAX']",0.9922811513964994,0,0,5
55,ACE Inhibitor Pathway WP554,0.2970244793995202,3.546279491833031,4.304973084443493,"['TGFB1', 'ATP6AP2']",0.9922811513964994,0,0,2
56,Type 2 papillary renal cell carcinoma WP4241,0.2970244793995202,3.546279491833031,4.304973084443493,"['TGFB1', 'ELOB']",0.9922811513964994,0,0,2
57,Type II interferon signaling (IFNG) WP619,0.2970244793995202,3.546279491833031,4.304973084443493,"['PRKCD', 'HLA-B']",0.9922811513964994,0,0,2
58,Vitamin D-sensitive calcium signaling in depression WP4698,0.2970244793995202,3.546279491833031,4.304973084443493,"['GPX4', 'PVALB']",0.9922811513964994,0,0,2
59,Cysteine and methionine catabolism WP4504,0.2970244793995202,3.546279491833031,4.304973084443493,"['GOT1', 'GSS']",0.9922811513964994,0,0,2
60,Neovascularisation processes WP4331,0.2970244793995202,3.546279491833031,4.304973084443493,"['TGFB1', 'KIT']",0.9922811513964994,0,0,2
61,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.2970244793995202,3.546279491833031,4.304973084443493,"['MAP1LC3A', 'FTL']",0.9922811513964994,0,0,2
62,Pre-implantation embryo WP3527,0.2970244793995202,3.546279491833031,4.304973084443493,"['DDIT3', 'ATP1A1']",0.9922811513964994,0,0,2
63,Pregnane X receptor pathway WP2876,0.2970244793995202,3.546279491833031,4.304973084443493,"['HSP90AA1', 'PSMC5']",0.9922811513964994,0,0,2
64,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.31757597256998255,1.7741347905282332,2.0350003865990685,"['TGFB1', 'CYCS', 'BAX', 'GADD45G']",0.9922811513964994,0,0,4
65,Modulators of TCR signaling and T cell activation WP5072,0.31757597256998255,1.7741347905282332,2.0350003865990685,"['FIBP', 'NDUFB10', 'ELOB', 'RNF7']",0.9922811513964994,0,0,4
66,Ciliary landscape WP4352,0.36096708031593755,1.4781021897810218,1.5061395934397814,"['PSMD8', 'VPS4A', 'COPS7A', 'MYL6B', 'LSM4']",0.9922811513964994,0,0,5
67,15q11.2 copy number variation syndrome WP4940,0.3612016502851796,inf,inf,['TUBGCP4'],0.9922811513964994,0,0,1
68,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3612016502851796,inf,inf,['TGFB1'],0.9922811513964994,0,0,1
69,16p11.2 distal deletion syndrome WP4950,0.3612016502851796,inf,inf,['CD81'],0.9922811513964994,0,0,1
70,Serotonin and anxiety WP3947,0.3612016502851796,inf,inf,['CRH'],0.9922811513964994,0,0,1
71,Serotonin and anxiety-related events WP3944,0.3612016502851796,inf,inf,['CRH'],0.9922811513964994,0,0,1
72,TCA cycle in senescence WP5050,0.3612016502851796,inf,inf,['GOT1'],0.9922811513964994,0,0,1
73,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.3612016502851796,inf,inf,['TGFB1'],0.9922811513964994,0,0,1
74,Biomarkers for urea cycle disorders WP4583,0.3612016502851796,inf,inf,['GOT1'],0.9922811513964994,0,0,1
75,Thiamine metabolic pathways WP4297,0.3612016502851796,inf,inf,['BCKDK'],0.9922811513964994,0,0,1
76,Cannabinoid receptor signaling WP3869,0.3612016502851796,inf,inf,['PRKAR1A'],0.9922811513964994,0,0,1
77,Canonical and non-canonical TGF-B signaling WP3874,0.3612016502851796,inf,inf,['TGFB1'],0.9922811513964994,0,0,1
78,Urea cycle and associated pathways WP4595,0.3612016502851796,inf,inf,['GOT1'],0.9922811513964994,0,0,1
79,Ebstein-Barr virus LMP1 signaling WP262,0.3612016502851796,inf,inf,['HSP90AA1'],0.9922811513964994,0,0,1
80,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.3612016502851796,inf,inf,['H3F3B'],0.9922811513964994,0,0,1
81,Energy Metabolism WP1541,0.3612016502851796,inf,inf,['PPRC1'],0.9922811513964994,0,0,1
82,EV release from cardiac cells and their functional effects WP3297,0.3612016502851796,inf,inf,['RGS16'],0.9922811513964994,0,0,1
83,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.3612016502851796,inf,inf,['GSS'],0.9922811513964994,0,0,1
84,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.3612016502851796,inf,inf,['GABBR1'],0.9922811513964994,0,0,1
85,Heart Development WP1591,0.3612016502851796,inf,inf,['VEGFB'],0.9922811513964994,0,0,1
86,HIF1A and PPARG regulation of glycolysis WP2456,0.3612016502851796,inf,inf,['LDHA'],0.9922811513964994,0,0,1
87,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3612016502851796,inf,inf,['ELOB'],0.9922811513964994,0,0,1
88,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.3612016502851796,inf,inf,['MAP1LC3A'],0.9922811513964994,0,0,1
89,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.3612016502851796,inf,inf,['TGFB1'],0.9922811513964994,0,0,1
90,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.3612016502851796,inf,inf,['GABRD'],0.9922811513964994,0,0,1
91,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3612016502851796,inf,inf,['VEGFB'],0.9922811513964994,0,0,1
92,Mitochondrial fatty acid synthesis pathway WP4317,0.3612016502851796,inf,inf,['HSD17B12'],0.9922811513964994,0,0,1
93,Mitochondrial Gene Expression WP391,0.3612016502851796,inf,inf,['PPRC1'],0.9922811513964994,0,0,1
94,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3612016502851796,inf,inf,['GOT1'],0.9922811513964994,0,0,1
95,Nanoparticle triggered autophagic cell death WP2509,0.3612016502851796,inf,inf,['MAP1LC3A'],0.9922811513964994,0,0,1
96,Nanoparticle triggered regulated necrosis WP2513,0.3612016502851796,inf,inf,['FTL'],0.9922811513964994,0,0,1
97,Non-homologous end joining WP438,0.3612016502851796,inf,inf,['DCLRE1C'],0.9922811513964994,0,0,1
98,Oxidative Stress WP408,0.3612016502851796,inf,inf,['TXN2'],0.9922811513964994,0,0,1
99,Peroxiredoxin 2 induced ovarian failure WP4873,0.3612016502851796,inf,inf,['BAX'],0.9922811513964994,0,0,1
100,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3612016502851796,inf,inf,['LDHA'],0.9922811513964994,0,0,1
101,Platelet-mediated interactions with vascular and circulating cells WP4462,0.3612016502851796,inf,inf,['TGFB1'],0.9922811513964994,0,0,1
102,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3612016502851796,inf,inf,['ANAPC11'],0.9922811513964994,0,0,1
103,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3729307696241337,1.161308840413318,1.1454714687931598,"['HSP90AA1', 'SET', 'TRPC3', 'PRKCD', 'RPL13A', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D']",0.9922811513964994,0,0,17
104,16p11.2 proximal deletion syndrome WP4949,0.3755239002494626,1.7727272727272727,1.7362678757339116,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9922811513964994,0,0,3
105,DNA damage response WP707,0.3755239002494626,1.7727272727272727,1.7362678757339116,"['CYCS', 'BAX', 'GADD45G']",0.9922811513964994,0,0,3
106,Eukaryotic Transcription Initiation WP405,0.3755239002494626,1.7727272727272727,1.7362678757339116,"['TAF13', 'POLR2I', 'POLR2K']",0.9922811513964994,0,0,3
107,AGE/RAGE pathway WP2324,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['PRKCD', 'CYCS']",0.9922811513964994,0,0,2
108,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['SFRP1', 'SST']",0.9922811513964994,0,0,2
109,Copper homeostasis WP3286,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['COX17', 'ATOX1']",0.9922811513964994,0,0,2
110,Cytosolic DNA-sensing pathway WP4655,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['POLR2K', 'POLR2L']",0.9922811513964994,0,0,2
111,DNA Mismatch Repair WP531,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['POLE4', 'POLE2']",0.9922811513964994,0,0,2
112,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['TGFB1', 'BANF1']",0.9922811513964994,0,0,2
113,Glycosylation and related congenital defects WP4521,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['DPM3', 'MPDU1']",0.9922811513964994,0,0,2
114,Mesodermal commitment pathway WP2857,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['PRKAR1A', 'RPL38']",0.9922811513964994,0,0,2
115,Methionine De Novo and Salvage Pathway WP3580,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['ODC1', 'SRM']",0.9922811513964994,0,0,2
116,Nucleotide Excision Repair WP4753,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['POLE4', 'POLE2']",0.9922811513964994,0,0,2
117,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.4569143719171501,1.7713248638838475,1.3874066297879444,"['HSP90AA1', 'BAX']",0.9922811513964994,0,0,2
118,IL-18 signaling pathway WP4754,0.4890513076754291,1.082410824108241,0.7742353342914714,"['TOMM40', 'USP5', 'CD81', 'TMSB4X', 'RGS16', 'PRKCD', 'RFX5', 'COX17', 'CYCS', 'BAX', 'NDUFC1']",0.9922811513964994,0,0,11
119,Small cell lung cancer WP4658,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['CYCS', 'BAX', 'GADD45G']",0.9922811513964994,0,0,3
120,Cardiac Progenitor Differentiation WP2406,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['MESP1', 'TGFB1', 'KIT']",0.9922811513964994,0,0,3
121,Endoderm differentiation WP2853,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['DUSP4', 'SFRP1', 'TGFB1']",0.9922811513964994,0,0,3
122,Endometrial cancer WP4155,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['BAX', 'FGF1', 'GADD45G']",0.9922811513964994,0,0,3
123,Fragile X Syndrome  WP4549,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['PRKAR1A', 'SLC6A1', 'GABRD']",0.9922811513964994,0,0,3
124,Melanoma WP4685,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['KIT', 'BAX', 'GADD45G']",0.9922811513964994,0,0,3
125,miRNA regulation of DNA damage response WP1530,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['CYCS', 'BAX', 'GADD45G']",0.9922811513964994,0,0,3
126,Non-small cell lung cancer WP4255,0.4934835739226566,1.3281818181818181,0.9380492688775396,"['CYCS', 'BAX', 'GADD45G']",0.9922811513964994,0,0,3
127,Androgen receptor signaling pathway WP138,0.5166832803621715,1.180327868852459,0.7794002392692739,"['SUMO1', 'KAT5', 'PARK7', 'FKBP4']",0.9922811513964994,0,0,4
128,Integrated breast cancer pathway WP1984,0.5166832803621715,1.180327868852459,0.7794002392692739,"['ODC1', 'BAX', 'PHB', 'FAU']",0.9922811513964994,0,0,4
129,Calcium Regulation in the Cardiac Cell WP536,0.5340917927399573,1.1062956204379562,0.6938548489157745,"['PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'ATP1B2']",0.9922811513964994,0,0,5
130,Signal transduction through IL1R WP4496,0.5920873142794576,1.769927536231884,0.9276210830619434,['TGFB1'],0.9922811513964994,0,0,1
131,Apoptosis Modulation by HSP70 WP384,0.5920873142794576,1.769927536231884,0.9276210830619434,['CYCS'],0.9922811513964994,0,0,1
132,Trans-sulfuration and one-carbon metabolism WP2525,0.5920873142794576,1.769927536231884,0.9276210830619434,['GSS'],0.9922811513964994,0,0,1
133,Trans-sulfuration pathway WP2333,0.5920873142794576,1.769927536231884,0.9276210830619434,['GOT1'],0.9922811513964994,0,0,1
134,Transcriptional cascade regulating adipogenesis WP4211,0.5920873142794576,1.769927536231884,0.9276210830619434,['DDIT3'],0.9922811513964994,0,0,1
135,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.5920873142794576,1.769927536231884,0.9276210830619434,['CCK'],0.9922811513964994,0,0,1
136,Constitutive Androstane Receptor Pathway WP2875,0.5920873142794576,1.769927536231884,0.9276210830619434,['HSP90AA1'],0.9922811513964994,0,0,1
137,Cytokines and Inflammatory Response WP530,0.5920873142794576,1.769927536231884,0.9276210830619434,['TGFB1'],0.9922811513964994,0,0,1
138,Dopaminergic Neurogenesis WP2855,0.5920873142794576,1.769927536231884,0.9276210830619434,['TGFB1'],0.9922811513964994,0,0,1
139,Dual hijack model of Vif in HIV infection WP3300,0.5920873142794576,1.769927536231884,0.9276210830619434,['ELOB'],0.9922811513964994,0,0,1
140,Fatty acid transporters WP5061,0.5920873142794576,1.769927536231884,0.9276210830619434,['FABP3'],0.9922811513964994,0,0,1
141,Galanin receptor pathway WP4970,0.5920873142794576,1.769927536231884,0.9276210830619434,['PRKCD'],0.9922811513964994,0,0,1
142,Gastric Cancer Network 2 WP2363,0.5920873142794576,1.769927536231884,0.9276210830619434,['FANCI'],0.9922811513964994,0,0,1
143,Genes targeted by miRNAs in adipocytes WP1992,0.5920873142794576,1.769927536231884,0.9276210830619434,['TMSB4X'],0.9922811513964994,0,0,1
144,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5920873142794576,1.769927536231884,0.9276210830619434,['TGFB1'],0.9922811513964994,0,0,1
145,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5920873142794576,1.769927536231884,0.9276210830619434,['LDHA'],0.9922811513964994,0,0,1
146,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5920873142794576,1.769927536231884,0.9276210830619434,['BAX'],0.9922811513964994,0,0,1
147,Joubert Syndrome WP4656,0.5920873142794576,1.769927536231884,0.9276210830619434,['KAT5'],0.9922811513964994,0,0,1
148,Kit receptor signaling pathway WP304,0.5920873142794576,1.769927536231884,0.9276210830619434,['KIT'],0.9922811513964994,0,0,1
149,Lipid Metabolism Pathway WP3965,0.5920873142794576,1.769927536231884,0.9276210830619434,['PRKAR1A'],0.9922811513964994,0,0,1
150,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.5920873142794576,1.769927536231884,0.9276210830619434,['BAX'],0.9922811513964994,0,0,1
151,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5920873142794576,1.769927536231884,0.9276210830619434,['BAX'],0.9922811513964994,0,0,1
152,Monoamine Transport WP727,0.5920873142794576,1.769927536231884,0.9276210830619434,['SLC6A1'],0.9922811513964994,0,0,1
153,MTHFR deficiency WP4288,0.5920873142794576,1.769927536231884,0.9276210830619434,['CYCS'],0.9922811513964994,0,0,1
154,Neural Crest Cell Migration during Development WP4564,0.5920873142794576,1.769927536231884,0.9276210830619434,['EPHB3'],0.9922811513964994,0,0,1
155,Neural Crest Cell Migration in Cancer WP4565,0.5920873142794576,1.769927536231884,0.9276210830619434,['EPHB3'],0.9922811513964994,0,0,1
156,Overview of nanoparticle effects WP3287,0.5920873142794576,1.769927536231884,0.9276210830619434,['BAX'],0.9922811513964994,0,0,1
157,Oxidation by Cytochrome P450 WP43,0.5920873142794576,1.769927536231884,0.9276210830619434,['CYB5R1'],0.9922811513964994,0,0,1
158,PKC-gamma calcium signaling pathway in ataxia WP4760,0.5920873142794576,1.769927536231884,0.9276210830619434,['TRPC3'],0.9922811513964994,0,0,1
159,Purinergic signaling WP4900,0.5920873142794576,1.769927536231884,0.9276210830619434,['P2RY14'],0.9922811513964994,0,0,1
160,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.5920873142794576,1.769927536231884,0.9276210830619434,['TGFB1'],0.9922811513964994,0,0,1
161,Alzheimer's disease WP2059,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['ATP5MD', 'CYCS']",0.9922811513964994,0,0,2
162,Aryl Hydrocarbon Receptor Netpath WP2586,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['HSP90AA1', 'AIP']",0.9922811513964994,0,0,2
163,ATM Signaling Network in Development and Disease  WP3878,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['DCLRE1C', 'KAT5']",0.9922811513964994,0,0,2
164,TNF-alpha signaling pathway WP231,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['HSP90AA1', 'BAX']",0.9922811513964994,0,0,2
165,TP53 network WP1742,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['SUMO1', 'BAX']",0.9922811513964994,0,0,2
166,Complement system WP2806,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['RPS19', 'CD59']",0.9922811513964994,0,0,2
167,Zinc homeostasis WP3529,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['SLC39A7', 'SLC39A3']",0.9922811513964994,0,0,2
168,IL-6 signaling pathway WP364,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['PRKCD', 'VIP']",0.9922811513964994,0,0,2
169,Lung fibrosis WP3624,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['TGFB1', 'FGF1']",0.9922811513964994,0,0,2
170,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['BAX', 'ANGPTL1']",0.9922811513964994,0,0,2
171,Retinoblastoma gene in cancer WP2446,0.5931750301854207,1.1796733212341197,0.6161029872294579,"['H2AFZ', 'POLE2']",0.9922811513964994,0,0,2
172,Allograft Rejection WP2328,0.5990280562888131,1.0614545454545454,0.543939031249849,"['TGFB1', 'COL5A1', 'HLA-B']",0.9922811513964994,0,0,3
173,Apoptosis WP254,0.5990280562888131,1.0614545454545454,0.543939031249849,"['HRK', 'CYCS', 'BAX']",0.9922811513964994,0,0,3
174,Cell cycle WP179,0.5990280562888131,1.0614545454545454,0.543939031249849,"['TGFB1', 'ANAPC11', 'GADD45G']",0.9922811513964994,0,0,3
175,Pathways Regulating Hippo Signaling WP4540,0.5990280562888131,1.0614545454545454,0.543939031249849,"['PRKAR1A', 'PRKCD', 'KIT']",0.9922811513964994,0,0,3
176,NRF2 pathway WP2884,0.6187648209635669,0.9642679075951471,0.462877535556581,"['HSP90AA1', 'TGFB1', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9922811513964994,0,0,6
177,MAPK Signaling Pathway WP382,0.6822586382513126,0.8832116788321168,0.3376928571164629,"['DUSP4', 'TGFB1', 'DDIT3', 'PRKCD', 'FGF1']",0.9922811513964994,0,0,5
178,Myometrial relaxation and contraction pathways WP289,0.6822586382513126,0.8832116788321168,0.3376928571164629,"['PRKAR1A', 'GNG4', 'RGS16', 'PRKCD', 'CRH']",0.9922811513964994,0,0,5
179,Spinal Cord Injury WP2431,0.6838219462598637,0.8834244080145719,0.3357522554648194,"['TGFB1', 'APEX1', 'OMG', 'SLIT3']",0.9922811513964994,0,0,4
180,G Protein Signaling Pathways WP35,0.6889337310429171,0.8836363636363637,0.3292519168395863,"['PRKAR1A', 'GNG4', 'PRKCD']",0.9922811513964994,0,0,3
181,Gastrin signaling pathway WP4659,0.6889337310429171,0.8836363636363637,0.3292519168395863,"['KAT5', 'PRKCD', 'KIT']",0.9922811513964994,0,0,3
182,B Cell Receptor Signaling Pathway WP23,0.7020004774702163,0.8838475499092558,0.31272399612955126,"['CD81', 'PRKCD']",0.9922811513964994,0,0,2
183,Chemokine signaling pathway WP3929,0.7020004774702163,0.8838475499092558,0.31272399612955126,"['GNG4', 'PRKCD']",0.9922811513964994,0,0,2
184,Genotoxicity pathway WP4286,0.7020004774702163,0.8838475499092558,0.31272399612955126,"['RPS27', 'PHLDA3']",0.9922811513964994,0,0,2
185,One-carbon metabolism and related pathways WP3940,0.7020004774702163,0.8838475499092558,0.31272399612955126,"['GPX4', 'GSS']",0.9922811513964994,0,0,2
186,Parkinson's disease pathway WP2371,0.7020004774702163,0.8838475499092558,0.31272399612955126,"['CYCS', 'PARK7']",0.9922811513964994,0,0,2
187,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.7354868135194027,0.8297895304910955,0.2549301531828311,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'FGF1']",0.9922811513964994,0,0,8
188,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7396185179866344,0.8840579710144928,0.266650221137465,['TGFB1'],0.9922811513964994,0,0,1
189,Sleep regulation WP3591,0.7396185179866344,0.8840579710144928,0.266650221137465,['CRH'],0.9922811513964994,0,0,1
190,Alanine and aspartate metabolism WP106,0.7396185179866344,0.8840579710144928,0.266650221137465,['GOT1'],0.9922811513964994,0,0,1
191,Alpha 6 Beta 4 signaling pathway WP244,0.7396185179866344,0.8840579710144928,0.266650221137465,['PRKCD'],0.9922811513964994,0,0,1
192,BMP Signaling Pathway in Eyelid Development WP3927,0.7396185179866344,0.8840579710144928,0.266650221137465,['SFRP1'],0.9922811513964994,0,0,1
193,Cell migration and invasion through p75NTR WP4561,0.7396185179866344,0.8840579710144928,0.266650221137465,['EFNB3'],0.9922811513964994,0,0,1
194,White fat cell differentiation WP4149,0.7396185179866344,0.8840579710144928,0.266650221137465,['DDIT3'],0.9922811513964994,0,0,1
195,Glycogen Synthesis and Degradation WP500,0.7396185179866344,0.8840579710144928,0.266650221137465,['PHKG1'],0.9922811513964994,0,0,1
196,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7396185179866344,0.8840579710144928,0.266650221137465,['FGF1'],0.9922811513964994,0,0,1
197,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7396185179866344,0.8840579710144928,0.266650221137465,['DDIT3'],0.9922811513964994,0,0,1
198,IL-3 signaling pathway WP286,0.7396185179866344,0.8840579710144928,0.266650221137465,['TGFB1'],0.9922811513964994,0,0,1
199,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7396185179866344,0.8840579710144928,0.266650221137465,['PRKCD'],0.9922811513964994,0,0,1
200,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.7396185179866344,0.8840579710144928,0.266650221137465,['GADD45G'],0.9922811513964994,0,0,1
201,Matrix Metalloproteinases WP129,0.7396185179866344,0.8840579710144928,0.266650221137465,['MMP16'],0.9922811513964994,0,0,1
202,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7396185179866344,0.8840579710144928,0.266650221137465,['B3GALT2'],0.9922811513964994,0,0,1
203,NRF2-ARE regulation WP4357,0.7396185179866344,0.8840579710144928,0.266650221137465,['AIMP2'],0.9922811513964994,0,0,1
204,Ovarian infertility WP34,0.7396185179866344,0.8840579710144928,0.266650221137465,['INHA'],0.9922811513964994,0,0,1
205,Oxidative Damage WP3941,0.7396185179866344,0.8840579710144928,0.266650221137465,['CYCS'],0.9922811513964994,0,0,1
206,Phytochemical activity on NRF2 transcriptional activation WP3,0.7396185179866344,0.8840579710144928,0.266650221137465,['AIMP2'],0.9922811513964994,0,0,1
207,Prion disease pathway WP3995,0.7396185179866344,0.8840579710144928,0.266650221137465,['RFX5'],0.9922811513964994,0,0,1
208,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.7396185179866344,0.8840579710144928,0.266650221137465,['BAX'],0.9922811513964994,0,0,1
209,Apoptosis Modulation and Signaling WP1772,0.7503686038950944,0.7844565877352763,0.22528865327936637,"['HRK', 'ENDOG', 'CYCS', 'BAX']",0.9922811513964994,0,0,4
210,Breast cancer pathway WP4262,0.7503686038950944,0.7844565877352763,0.22528865327936637,"['KIT', 'BAX', 'FGF1', 'GADD45G']",0.9922811513964994,0,0,4
211,TGF-beta Signaling Pathway WP366,0.7627552595925182,0.7566233766233766,0.20490727488954713,"['TGFB1', 'PARD6A', 'SUMO1']",0.9922811513964994,0,0,3
212,Nuclear Receptors Meta-Pathway WP2882,0.7771264327978954,0.7924632352941177,0.19982136617017537,"['PSMC5', 'HSP90AA1', 'TGFB1', 'AIP', 'BAX', 'SLC39A7', 'SLC6A1', 'SLC39A3', 'FTL']",0.9922811513964994,0,0,9
213,22q11.2 copy number variation syndrome WP4657,0.7854071180966079,0.7063520871143376,0.17062151786876853,"['RANBP1', 'MRPL40']",0.9922811513964994,0,0,2
214,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.7854071180966079,0.7063520871143376,0.17062151786876853,"['PDGFC', 'BAX']",0.9922811513964994,0,0,2
215,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.7854071180966079,0.7063520871143376,0.17062151786876853,"['MAP1LC3A', 'DDIT3']",0.9922811513964994,0,0,2
216,Hippo-Merlin Signaling Dysregulation WP4541,0.7854071180966079,0.7063520871143376,0.17062151786876853,"['PRKAR1A', 'KIT']",0.9922811513964994,0,0,2
217,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7854071180966079,0.7063520871143376,0.17062151786876853,"['IFI27L2', 'PRKCD']",0.9922811513964994,0,0,2
218,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7854071180966079,0.7063520871143376,0.17062151786876853,"['PSMD8', 'PSMC5']",0.9922811513964994,0,0,2
219,3q29 copy number variation syndrome WP4906,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
220,Target Of Rapamycin (TOR) Signaling WP1471,0.8338530477066014,0.5887681159420289,0.1069780444389556,['RRAGA'],0.9922811513964994,0,0,1
221,BDNF-TrkB Signaling WP3676,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TRPC3'],0.9922811513964994,0,0,1
222,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
223,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
224,Cardiac Hypertrophic Response WP2795,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
225,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8338530477066014,0.5887681159420289,0.1069780444389556,['PRKCD'],0.9922811513964994,0,0,1
226,Tumor suppressor activity of SMARCB1 WP4204,0.8338530477066014,0.5887681159420289,0.1069780444389556,['H3F3B'],0.9922811513964994,0,0,1
227,Unfolded protein response WP4925,0.8338530477066014,0.5887681159420289,0.1069780444389556,['DDIT3'],0.9922811513964994,0,0,1
228,DNA Replication WP466,0.8338530477066014,0.5887681159420289,0.1069780444389556,['POLE2'],0.9922811513964994,0,0,1
229,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
230,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.8338530477066014,0.5887681159420289,0.1069780444389556,['CD81'],0.9922811513964994,0,0,1
231,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.8338530477066014,0.5887681159420289,0.1069780444389556,['MAP1LC3A'],0.9922811513964994,0,0,1
232,Integrated Cancer Pathway WP1971,0.8338530477066014,0.5887681159420289,0.1069780444389556,['BAX'],0.9922811513964994,0,0,1
233,Interleukin-11 Signaling Pathway WP2332,0.8338530477066014,0.5887681159420289,0.1069780444389556,['TGFB1'],0.9922811513964994,0,0,1
234,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.8338530477066014,0.5887681159420289,0.1069780444389556,['RAB3A'],0.9922811513964994,0,0,1
235,Leptin signaling pathway WP2034,0.8338530477066014,0.5887681159420289,0.1069780444389556,['BAX'],0.9922811513964994,0,0,1
236,miR-509-3p alteration of YAP1/ECM axis WP3967,0.8338530477066014,0.5887681159420289,0.1069780444389556,['COL5A1'],0.9922811513964994,0,0,1
237,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.8338530477066014,0.5887681159420289,0.1069780444389556,['OMG'],0.9922811513964994,0,0,1
238,Prader-Willi and Angelman Syndrome WP3998,0.8338530477066014,0.5887681159420289,0.1069780444389556,['GABRD'],0.9922811513964994,0,0,1
239,Regulation of Microtubule Cytoskeleton WP2038,0.8338530477066014,0.5887681159420289,0.1069780444389556,['PARD6A'],0.9922811513964994,0,0,1
240,Regulation of toll-like receptor signaling pathway WP1449,0.8338530477066014,0.5887681159420289,0.1069780444389556,['PELI3'],0.9922811513964994,0,0,1
241,Senescence and Autophagy in Cancer WP615,0.8382434548493027,0.6772880404267265,0.11950524088782911,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'GABARAP', 'SLC39A3']",0.9922811513964994,0,0,5
242,Exercise-induced Circadian Regulation WP410,0.8475333504754277,0.588021778584392,0.09727355500237526,"['DAZAP2', 'SUMO1']",0.9922811513964994,0,0,2
243,Metapathway biotransformation Phase I and II WP702,0.8475333504754277,0.588021778584392,0.09727355500237526,"['GPX4', 'GSS']",0.9922811513964994,0,0,2
244,PI3K-Akt signaling pathway WP4172,0.8641129252272899,0.6595063985374772,0.09632210863682543,"['HSP90AA1', 'GNG4', 'PDGFC', 'KIT', 'VEGFB', 'FGF1']",0.9922811513964994,0,0,6
245,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8676118169800997,0.5872727272727273,0.08339911669027412,"['PRKAR1A', 'SST', 'ATP1A3']",0.9922811513964994,0,0,3
246,T-cell receptor (TCR) signaling pathway WP69,0.8928474072562109,0.5035001296344309,0.05706649787479868,"['TGFB1', 'PRKCD']",0.9922811513964994,0,0,2
247,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8928474072562109,0.5035001296344309,0.05706649787479868,"['RAB3A', 'PRKCD']",0.9922811513964994,0,0,2
248,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.894022380277651,0.4411231884057971,0.04941659149806764,['TMSB4X'],0.9922811513964994,0,0,1
249,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.894022380277651,0.4411231884057971,0.04941659149806764,['APEX1'],0.9922811513964994,0,0,1
250,DNA IR-damage and cellular response via ATR WP4016,0.894022380277651,0.4411231884057971,0.04941659149806764,['FANCI'],0.9922811513964994,0,0,1
251,Folate Metabolism WP176,0.894022380277651,0.4411231884057971,0.04941659149806764,['GPX4'],0.9922811513964994,0,0,1
252,G1 to S cell cycle control WP45,0.894022380277651,0.4411231884057971,0.04941659149806764,['POLE2'],0.9922811513964994,0,0,1
253,MET in type 1 papillary renal cell carcinoma WP4205,0.894022380277651,0.4411231884057971,0.04941659149806764,['RPL11'],0.9922811513964994,0,0,1
254,miRNA targets in ECM and membrane receptors WP2911,0.894022380277651,0.4411231884057971,0.04941659149806764,['COL5A1'],0.9922811513964994,0,0,1
255,p38 MAPK Signaling Pathway WP400,0.894022380277651,0.4411231884057971,0.04941659149806764,['DDIT3'],0.9922811513964994,0,0,1
256,PPAR signaling pathway WP3942,0.894022380277651,0.4411231884057971,0.04941659149806764,['FABP3'],0.9922811513964994,0,0,1
257,DNA damage response (only ATM dependent) WP710,0.925370327607165,0.4401088929219601,0.03413540353790667,"['TGFB1', 'BAX']",0.9922811513964994,0,0,2
258,Ebola Virus Pathway on Host WP4217,0.925370327607165,0.4401088929219601,0.03413540353790667,"['VPS4A', 'HLA-B']",0.9922811513964994,0,0,2
259,EGF/EGFR signaling pathway WP437,0.925370327607165,0.4401088929219601,0.03413540353790667,"['NDUFA13', 'PRKCD']",0.9922811513964994,0,0,2
260,Osteoblast differentiation WP4787,0.925370327607165,0.4401088929219601,0.03413540353790667,"['PRKCD', 'FGF1']",0.9922811513964994,0,0,2
261,Ras signaling WP4223,0.925370327607165,0.4401088929219601,0.03413540353790667,"['GNG4', 'KIT']",0.9922811513964994,0,0,2
262,Adipogenesis WP236,0.9292917443833476,0.479504132231405,0.03516325986599428,"['WWTR1', 'TGFB1', 'DDIT3']",0.9922811513964994,0,0,3
263,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9324266003203089,0.35253623188405797,0.024665142240876504,['TGFB1'],0.9922811513964994,0,0,1
264,TGF-beta Receptor Signaling WP560,0.9324266003203089,0.35253623188405797,0.024665142240876504,['TGFB1'],0.9922811513964994,0,0,1
265,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9324266003203089,0.35253623188405797,0.024665142240876504,['TGFB1'],0.9922811513964994,0,0,1
266,Fas ligand pathway and stress induction of heat shock proteins WP314,0.9324266003203089,0.35253623188405797,0.024665142240876504,['CYCS'],0.9922811513964994,0,0,1
267,Glucocorticoid Receptor Pathway WP2880,0.9324266003203089,0.35253623188405797,0.024665142240876504,['HSP90AA1'],0.9922811513964994,0,0,1
268,Imatinib and Chronic Myeloid Leukemia WP3640,0.9324266003203089,0.35253623188405797,0.024665142240876504,['KIT'],0.9922811513964994,0,0,1
269,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9324266003203089,0.35253623188405797,0.024665142240876504,['TGFB1'],0.9922811513964994,0,0,1
270,p53 transcriptional gene network WP4963,0.9324266003203089,0.35253623188405797,0.024665142240876504,['BAX'],0.9922811513964994,0,0,1
271,Phosphodiesterases in neuronal function WP4222,0.9324266003203089,0.35253623188405797,0.024665142240876504,['PDE3A'],0.9922811513964994,0,0,1
272,Photodynamic therapy-induced unfolded protein response WP3613,0.9324266003203089,0.35253623188405797,0.024665142240876504,['DDIT3'],0.9922811513964994,0,0,1
273,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9484159728741915,0.39080459770114945,0.020697825546324666,"['BEX3', 'RNF7']",0.9922811513964994,0,0,2
274,Regulation of Actin Cytoskeleton WP51,0.9484159728741915,0.39080459770114945,0.020697825546324666,"['TMSB4X', 'FGF1']",0.9922811513964994,0,0,2
275,Wnt signaling WP428,0.956929698299778,0.29347826086956524,0.012920483366218451,['SFRP1'],0.9922811513964994,0,0,1
276,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.956929698299778,0.29347826086956524,0.012920483366218451,['SFRP1'],0.9922811513964994,0,0,1
277,MECP2 and Associated Rett Syndrome WP3584,0.956929698299778,0.29347826086956524,0.012920483366218451,['SST'],0.9922811513964994,0,0,1
278,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.956929698299778,0.29347826086956524,0.012920483366218451,['SFRP1'],0.9922811513964994,0,0,1
279,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.956929698299778,0.29347826086956524,0.012920483366218451,['TGFB1'],0.9922811513964994,0,0,1
280,Wnt signaling pathway and pluripotency WP399,0.9725576109689862,0.25129399585921325,0.006992497977018374,['PRKCD'],0.9922811513964994,0,0,1
281,Development of ureteric collection system WP5053,0.9725576109689862,0.25129399585921325,0.006992497977018374,['GDF11'],0.9922811513964994,0,0,1
282,Glioblastoma signaling pathways WP2261,0.9725576109689862,0.25129399585921325,0.006992497977018374,['PRKCD'],0.9922811513964994,0,0,1
283,Circadian rhythm related genes WP3594,0.9758115115262005,0.3190892591981521,0.007813166841246373,"['CRH', 'RPS27A']",0.9922811513964994,0,0,2
284,Vitamin D Receptor Pathway WP2877,0.9758115115262005,0.3190892591981521,0.007813166841246373,"['SFRP1', 'TGFB1']",0.9922811513964994,0,0,2
285,Insulin Signaling WP481,0.9758115115262005,0.3190892591981521,0.007813166841246373,"['PRKCD', 'PFKM']",0.9922811513964994,0,0,2
286,ESC Pluripotency Pathways WP3931,0.9825212610705434,0.21965579710144928,0.00387325562391502,['FGF1'],0.9922811513964994,0,0,1
287,Oncostatin M Signaling Pathway WP2374,0.9825212610705434,0.21965579710144928,0.00387325562391502,['PRKCD'],0.9922811513964994,0,0,1
288,Focal Adhesion WP306,0.9835647138570066,0.29219600725952816,0.004842226581980401,"['PDGFC', 'VEGFB']",0.9922811513964994,0,0,2
289,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9888712505325941,0.19504830917874397,0.002182812407620009,['TGFB1'],0.9922811513964994,0,0,1
290,Endochondral Ossification WP474,0.9888712505325941,0.19504830917874397,0.002182812407620009,['TGFB1'],0.9922811513964994,0,0,1
291,"GPCRs, Class A Rhodopsin-like WP455",0.9966320813385519,0.21823956442831216,0.0007362536199681187,"['P2RY14', 'MCHR1']",0.9966320813385519,0,0,2
